Differential Diagnostics of Endometrial Cancer/Atypical Glandular Hyperplasia: Electron Microscopic Examination
DOI:
https://doi.org/10.5281/zenodo.18047637Keywords:
Atypical Glandular Hyperplasia , Endometrial Cancer , Malignancy , Proliferation , Electron MicroscopyAbstract
This study highlights the significance of electron microscopic analysis in diagnosing proliferative changes associated with endometrial cancer, since the cytological investigations utilizing electron microscopy are of considerable scientific and clinical value for identifying atypical cells. Purpose of the study was to assess the diagnostic importance of electron microscopic examination in detecting proliferative alterations in endometrial cancer. Materials and Methods. The research involved 132 patients diagnosed with endometrial adenocarcinoma (main group) and 35 patients with atypical glandular hyperplasia (control group). Surgical specimens obtained from patients with uterine cancer were submitted to the electron microscopy laboratory for examination using both light and electron microscopy techniques. Findings. Atypical glandular hyperplasia is primarily characterized by the formation of basement membrane invaginations, mitochondrial swelling, roughened mitochondrial cristae, and engorgement of interstitial stromal capillaries. In well-differentiated adenocarcinomas, some cells exhibited structural deformation of desmosomes and a reduction in their number. In G2-grade tumors, the number of desmosomes further decreased, while in G3 tumors, the few desmosomes present showed complete disintegration. Less than 20% of cells in well-differentiated adenocarcinomas demonstrated degradation of desmosomes, accompanied by mild nuclear deformation, mitochondrial swelling, and partial fragmentation of mitochondrial cristae. In poorly differentiated tumors, over 50% of cells exhibited complete desmosomal degradation, marked nuclear polymorphism, and total fragmentation of mitochondrial cristae. Conclusion. The findings underscore the utility of electron microscopy in evaluating the morphological features of endometrial tissue, aiding in the prediction of proliferative disease progression in patients.References
Amirova, M. F., Mammadova, K. R., & Huseynova, E. E. (2020). Cancer development under tobacco, alcohol, and opportunistic microbiota action and its reduction with oleuropein. Journal of Pathology and Infectious Diseases, 3(2), 1–3.
Amirova, M. F., Huseynova, E. E., Aliyev, A. N., et al. (2025). Impact of vitamin D levels drop on endometria hyperplastic post-menopausal bleeding. Surgical Clinics and Practice, 2(1), 1–5. [CrossRef]
American Cancer Society. (2025). Key Statistics for Endometrial Cancer. Retrieved from https:// www.cancer.org/
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. [CrossRef] [PubMed]
GBD 2019 Collaborators. (2020). Global burden of uterine cancer, 1990–2019: Updated results from the Global Burden of Disease Study.
Yang L., Yuan, Y., Zhu, R., and Zhang, X. (2023).Time trend of global uterine cancer burden: an age-period-cohort analysis from 1990 to 2019 and predictions in a 25-year period. BMC Women's Health, 23:384. [CrossRef] [PubMed]
Giannella, L., Piva, F., Delli Carpini, G., Di Giuseppe, J., Grelloni, C., Giulietti, M., Ciavattini, A. (2024). Concurrent endometrial cancer in women with atypical endometrial hyperplasia: What is the predictive value of patient characteristics? Cancers, 16(1), 172. [CrossRef] [PubMed]
Lai, X., Chen, Y., & Wang, J. (2022). Atypical endometrial hyperplasia and risk of endometrial cancer: A multicenter retrospective study. Frontiers in Oncology, 12, 892995. [CrossRef] [PubMed]
Nicola, G., Chang, A., & Gupta, P. (2024). Concurrent endometrial carcinoma in atypical endometrial hyperplasia: Systematic review and meta-analysis. International Journal of Gynecological Cancer, 34(1), 66–72. [CrossRef] [PubMed]
Smith, R., Patel, A., & Lee, S. (2022). Global trends in endometrial cancer incidence and mortality from 1990 to 2021. BMC Women’s Health, 23, 2535. [CrossRef] [PubMed]
Nguyen, L. T., Smith, C. A., & Huang, H. (2021). Endometrial intraepithelial neoplasia and early carcinoma: Morphologic insights and clinical implications. Human Pathology, 117, 35–42.
Torres Rodríguez, C., Gómez Sánchez, A., & Morales Montes, C. (2023). Nuclear and glandular degeneration in endometrial proliferative lesions: A morphological spectrum. International Journal of Gynecological Pathology, 42(3), 180–188.
Sato, M., Yoshida, Y., Watanabe, T., & Suzuki, Y. (2022). Endometrial sampling accuracy and patient outcomes: A comparative study of biopsy methods. European Journal of Obstetrics & Gynecology and Reproductive Biology, 269, 150–156.
Zhao, J., Liu, Y., & Wu, N. (2024). Diagnostic utility of high-resolution electron microscopy in endometrial cytology. Cytopathology, 35(1), 61–69.
Al Kabsi, A., & Patel, R. (2023). Ultrastructure of atypical endometrial cells on electron microscopy: Implications for early EC detection. Journal of Women’s Health, 32(2), 190–198.
Li, X., Chen, Y., & Zhang, Z. (2023). Clinicopathologic factors and long-term outcomes in endometrial carcinoma: A nationwide cohort study. Gynecologic Oncology, 172(1), 45–52.
Wang, F., & Humphrey, P. A. (2022). Morphologic and molecular correlates of tumor grade in endometrial carcinoma. Archives of Pathology & Laboratory Medicine, 146(5), e123–e131.
